Literature DB >> 15192903

Vaccine coverage levels after implementation of a middle school vaccination requirement, Florida, 1997-2000.

Kieran J Fogarty1, Mehran S Massoudi, William Gallo, Francisco M Averhoff, Hussain Yusuf, Daniel Fishbein.   

Abstract

OBJECTIVE: Little information is available about the effectiveness of school entry vaccination requirements at the middle school level. This study examined coverage levels among students entering seventh grade in Florida following implementation of a school entry vaccination requirement in 1997.
METHODS: The authors analyzed county-specific vaccination coverage levels (three doses of hepatitis B vaccine, a second dose of measles, mumps, and rubella [MMR] vaccine, and a booster dose of tetanus and diphtheria toxoids [Td]) among students entering public and private schools in Florida from 1997 through 2000. In 1998, a survey of all county health departments was conducted, and the resulting data were linked to county-specific vaccination rates.
RESULTS: During the 1997-1998 school year, the first year the requirement went into effect, at school entry 121,219 seventh-grade students (61.8%) were fully vaccinated, 72,275 seventh grade students (36.9%) lacked one or more doses of vaccine but were considered in process, 1,817 were non-compliant (0.9%), and 763 had medical or religious exemptions (0.4%). In the 2000-2001 school year, the proportions of students reported fully vaccinated at school entry had increased to 66%. Most of this change was related to an increase in hepatitis B coverage. There was a significant inverse relationship between the proportion of students fully vaccinated and the size of the county's seventh grade population.
CONCLUSIONS: The seventh grade vaccination entry requirement was associated with sustained high levels of vaccination coverage. Passing a school entry vaccination requirement appears may be sufficient to increase coverage, but other strategies may be required to achieve full immunization of middle school students.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15192903      PMCID: PMC1497615          DOI: 10.1177/003335490411900209

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  4 in total

1.  Implementing a seventh grade vaccination law: school factors associated with completion of required immunizations.

Authors:  Leslie S Linton; K Michael Peddecord; Robert L Seidman; Christine Edwards; Sandra Ross; Kathleen Gustafson; Francisco Averhoff; Daniel B Fishbein
Journal:  Prev Med       Date:  2003-04       Impact factor: 4.018

2.  Adolescent immunization: rationale, recommendations, and implementation strategies.

Authors:  H Yusuf; F Averhoff; N Smith; E Brink
Journal:  Pediatr Ann       Date:  1998-07       Impact factor: 1.132

3.  The impact of college prematriculation immunization requirements on risk for measles outbreaks.

Authors:  A L Baughman; W W Williams; W L Atkinson; L G Cook; M Collins
Journal:  JAMA       Date:  1994-10-12       Impact factor: 56.272

4.  The immunization system in the United States - the role of school immunization laws.

Authors:  W A Orenstein; A R Hinman
Journal:  Vaccine       Date:  1999-10-29       Impact factor: 3.641

  4 in total
  12 in total

1.  Vaccine beliefs of parents who oppose compulsory vaccination.

Authors:  Allison M Kennedy; Cedric J Brown; Deborah A Gust
Journal:  Public Health Rep       Date:  2005 May-Jun       Impact factor: 2.792

2.  Determining accurate vaccination coverage rates for adolescents: the National Immunization Survey-Teen 2006.

Authors:  Nidhi Jain; James A Singleton; Margrethe Montgomery; Benjamin Skalland
Journal:  Public Health Rep       Date:  2009 Sep-Oct       Impact factor: 2.792

3.  Routine vaccination coverage of children aged 1-7 years in Zhejiang province, China.

Authors:  Yu Hu; Yaping Chen; Hui Liang; Ying Wang
Journal:  Hum Vaccin Immunother       Date:  2018-08-27       Impact factor: 3.452

4.  Parental Hesitancy About Routine Childhood and Influenza Vaccinations: A National Survey.

Authors:  Allison Kempe; Alison W Saville; Christina Albertin; Gregory Zimet; Abigail Breck; Laura Helmkamp; Sitaram Vangala; L Miriam Dickinson; Cindy Rand; Sharon Humiston; Peter G Szilagyi
Journal:  Pediatrics       Date:  2020-06-15       Impact factor: 7.124

5.  Impact of Provider Recommendation on Tdap Vaccination of Adolescents Aged 13-17 Years.

Authors:  Peng-Jun Lu; David Yankey; Jenny Jeyarajah; Alissa O'Halloran; Sarah A Meyer; Laurie D Elam-Evans; Sarah Reagan-Steiner
Journal:  Am J Prev Med       Date:  2017-05-08       Impact factor: 5.043

6.  Compliance with recommended immunizations in adolescents.

Authors:  Ulrich Heininger; Kerstin Loos; Imke Lorenz; Wolfgang Rascher
Journal:  Eur J Pediatr       Date:  2006-05-18       Impact factor: 3.183

7.  The effect of vaccinated children on increased hepatitis B immunization among high-risk adults.

Authors:  Deepika L Koya; Elizabeth G Hill; Paul M Darden
Journal:  Am J Public Health       Date:  2008-04-01       Impact factor: 9.308

8.  Human papillomavirus (HPV) vaccine availability, recommendations, cost, and policies among health departments in seven Appalachian states.

Authors:  Mira L Katz; Paul L Reiter; Brenda C Kluhsman; Stephenie Kennedy; Sharon Dwyer; Nancy Schoenberg; Andy Johnson; Gretchen Ely; Karen A Roberto; Eugene J Lengerich; Pamela Brown; Electra D Paskett; Mark Dignan
Journal:  Vaccine       Date:  2009-04-07       Impact factor: 3.641

9.  US college and university student health screening requirements for tuberculosis and vaccine-preventable diseases, 2012.

Authors:  Amy Jewett; Teal Bell; Nicole J Cohen; Kirsten Buckley; E Victor Leino; Susan Even; Suzanne Beavers; Clive Brown; Nina Marano
Journal:  J Am Coll Health       Date:  2016-01-05

10.  Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality.

Authors:  Suchita A Lorick; Daniel Fishbein; Eric Weintraub; Pascale M Wortley; Grace M Lee; Fangjun Zhou; Robert Davis
Journal:  BMC Infect Dis       Date:  2009-11-03       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.